New treatment paradigms are making biopharma industry stakeholder communications more ambitious and complex. But they must ...

Given the near-constant technological advancements in AI, potential AI policy updates, and regulatory changes, flexible AI ...

LB Pharmaceuticals CEO Heather Turner explains why 18 years as a general counsel provided her with an advantageous ...

This article is the second installment of a three-part series aimed at helping drug and device manufacturers better navigate and understand the VA and DOD health systems. The first installment in the ...